A5041923034- Bladder and Urothelial Cancer Treatments
- Urinary and Genital Oncology Studies
- Urological Disorders and Treatments
- Renal cell carcinoma treatment
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Cancer, Lipids, and Metabolism
- Esophageal Cancer Research and Treatment
- Kidney Stones and Urolithiasis Treatments
- Pediatric Urology and Nephrology Studies
- Renal and related cancers
- Colorectal Cancer Screening and Detection
- Epigenetics and DNA Methylation
- Ferroptosis and cancer prognosis
- Cancer Research and Treatments
- Multiple and Secondary Primary Cancers
- Metabolomics and Mass Spectrometry Studies
- Urinary Bladder and Prostate Research
- Urinary Tract Infections Management
- Urologic and reproductive health conditions
- Cancer, Hypoxia, and Metabolism
- Cancer Immunotherapy and Biomarkers
- Health Systems, Economic Evaluations, Quality of Life
- Testicular diseases and treatments
- Peptidase Inhibition and Analysis
The University of Texas Southwestern Medical Center
2016-2025
Southwestern Medical Center
2016-2025
Southwestern University
2017-2024
American Urological Association
2017-2024
Weatherford College
2024
GTx (United States)
2013-2021
Fondazione IRCCS Istituto Nazionale dei Tumori
2020
Iowa City Public Library
2019-2020
Nashville Oncology Associates
2020
Madison Group (United States)
2020
The literature on upper tract urothelial carcinoma (UTUC) has been limited to small, single center studies. A large series of patients treated with radical nephroureterectomy for UTUC were studied, and variables associated poor prognosis identified.Data 1363 at 12 academic centers collected. All pathologic slides re-reviewed by genitourinary pathologists according strict criteria.Pathologic review revealed renal pelvis location (64%), necrosis (21.6%), lymphovascular invasion (LVI) (24.8%),...
This multidisciplinary, evidence-based guideline for clinically non-metastatic muscle-invasive bladder cancer focuses on the evaluation, treatment and surveillance of guided toward curative intent.A systematic review utilizing research from Agency Healthcare Research Quality as well additional supplementation by authors consultant methodologists was used to develop guideline. Evidence-based statements were based body evidence strengths Grade A, B or C designated Strong, Moderate Conditional...
We present the characteristics and outcomes of a large, contemporary, consecutive series patients treated with radical cystectomy pelvic lymphadenectomy for transitional cell carcinoma bladder.We developed multi-institutional database collected retrospective prospective data on 888 bladder who were at 3 academic centers in United States between 1984 2003.Of 25% had extravesical tumor extension negative lymph nodes 23% node metastasis. The rate involvement increased advancing pathological...
An unanticipated result of global warming is the likely northward expansion present-day southeastern U.S. kidney stone "belt." The fraction population living in high-risk zones for nephrolithiasis will grow from 40% 2000 to 56% by 2050, and 70% 2095. Predictions based on a climate model intermediate severity (SRESa1b) indicate climate-related increase 1.6-2.2 million lifetime cases representing up 30% some divisions. Nationwide, cost associated with this rise would be $0.9-1.3 billion...
Purpose To assess the association of lymphovascular invasion (LVI) with cancer recurrence and survival in a large international series patients treated radical nephroureterectomy (RNU) for upper urinary tract urothelial carcinoma (UTUC). Patients Methods Data were collected on 1,453 RNU at 13 academic centers combined into relational database. Pathologic slides rereviewed by genitourinary pathologists according to strict criteria. LVI was defined as presence tumor cells within an...
Given the limited sensitivity and specificity of prostate-specific antigen (PSA), its widespread use as a screening tool has raised concerns for overdiagnosis low-risk underdiagnosis high-grade prostate cancer. To improve early-detection biopsy decisions, National Cancer Institute conducted prospective validation trial to assess diagnostic performance cancer 3 (PCA3) urinary assay detection among men screened with PSA.